Add to ORKGShanmugam examines the relevant and urgent issue of exorbitantly high pharmaceutical prices, particularly as it relates to patent law. Shanmugam’s essay starts by outlining the Hatch-Waxman Act and its implications, and then presents a balanced analysis of the effectiveness of Maryland’s HB 631 law to curb price-gouging of generic drugs
International audienceThe evolution of pharmaceutical competition since Congress passed the Hatch-Wa...
International audienceThe evolution of pharmaceutical competition since Congress passed the Hatch-Wa...
A tidal wave of high drug prices has recently crashed across the U.S. economy. One of the primary cu...
This note acknowledges that the high cost of drugs, both generic and patented, is an important issue...
The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman...
Without a doubt, health care costs are on the rise, and how to reduce those costs is of great concer...
The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman...
Pricing prescription pharmaceuticals is a complex process that entails the consideration of a multit...
The Hatch-Waxman Act of 1984 established a system whereby generic manufacturers can seek to market g...
High drug prices are creating serious health and fiscal problems in the United States to...
The Hatch-Waxman Act was intended to establish a balance between the competing interests of brand na...
This Article discusses drug pricing in the context of federally funded inventions. It examines the “...
This paper explores the complex connections among intellectual property protection, competition, and...
Recent reports have highlighted dramatic price increases for several older generic drugs, including ...
When generic drugs seek FDA approval, the pharmaceutical company files an Abbreviated New Drug Appli...
International audienceThe evolution of pharmaceutical competition since Congress passed the Hatch-Wa...
International audienceThe evolution of pharmaceutical competition since Congress passed the Hatch-Wa...
A tidal wave of high drug prices has recently crashed across the U.S. economy. One of the primary cu...
This note acknowledges that the high cost of drugs, both generic and patented, is an important issue...
The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman...
Without a doubt, health care costs are on the rise, and how to reduce those costs is of great concer...
The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman...
Pricing prescription pharmaceuticals is a complex process that entails the consideration of a multit...
The Hatch-Waxman Act of 1984 established a system whereby generic manufacturers can seek to market g...
High drug prices are creating serious health and fiscal problems in the United States to...
The Hatch-Waxman Act was intended to establish a balance between the competing interests of brand na...
This Article discusses drug pricing in the context of federally funded inventions. It examines the “...
This paper explores the complex connections among intellectual property protection, competition, and...
Recent reports have highlighted dramatic price increases for several older generic drugs, including ...
When generic drugs seek FDA approval, the pharmaceutical company files an Abbreviated New Drug Appli...
International audienceThe evolution of pharmaceutical competition since Congress passed the Hatch-Wa...
International audienceThe evolution of pharmaceutical competition since Congress passed the Hatch-Wa...
A tidal wave of high drug prices has recently crashed across the U.S. economy. One of the primary cu...